With over 20 years of experience, BB Biotech focuses on the fast-growing biotechnology market, employing fundamental analysis to build its portfolio. The company primarily invests in listed companies that are involved in modern biotechnology for medications and diagnostics. Headquartered in Switzerland, BB Biotech is one of the largest investors in the biotech sector. Its shares are listed on multiple stock exchanges, including SIX Swiss Exchange, Frankfurt Stock Exchange, and the Stock Exchange in Milan. BB Biotech's investments are centered around companies that develop and commercialize innovative drugs, providing value to the healthcare system.